Tanios S. Bekaii-Saab, M.D.

Location

  1. Phoenix, Arizona

Languages

ArabicEnglishFrench

Tanios Bekaii-Saab, M.D., F.A.C.P. is a medical oncologist with a specific focus in gastrointestinal cancers.

In additional to his clinical activities, Dr. Bekaii-Saab serves as the leader of the Gastrointestinal Cancer Program at the Mayo Clinic Cancer Center. He is also the medical director of the Cancer Clinical Research Office as well as the Vice Chair and Section Chief for Medical Oncology in the Department of Internal Medicine at the Mayo Clinic in Phoenix, Arizona, USA. Additionally, he serves as the consortium chair for the ACCRU research Network.

Dr. Bekaii-Saab's research interests in gastrointestinal cancers are focused on the incorporation of agents that target the multiple facets of cancer, including genetic and epigenetic drivers as well as the feeding microenvironment and the immune milieu. The overarching goal of his work is helping patients to identify those approaches best suited for their individual situation.

  • Gastrointestinal oncology
  • Clinical trials in oncology
  • Early cancer therapeutics
  • Precision oncology
  1. 2002
    Fellow - Clinical Pharmacology and Experimental TherapeuticsTufts University School of Medicine
  2. 2002
    Fellow - Hematology-OncologyTufts-New England Medical Center
  3. 1999
    Residency - Internal MedicineIndiana University Medical Center
  4. 1996
    MDAmerican University of Beirut
  5. 1992
    BSc - (Neuro) BiologyMcGill University
  6. 1989
    Undergraduate StudiesAmerican University of Beirut
  7. 1987
    Undergraduate Studies - Faculty of MedicineUniversity of Montpellier

Awards and honors

  1. 2013
    Best Doctors in AmericaBest Doctors
  2. 2012
    Leadership Development Award ProgramAmerican Society of Clinical Oncology
  3. 2012
    Top 10 DoctorVitals
  4. 2011
    Clinical Investigator Team Leadership AwardNational Cancer Institute
  5. 2010
    Top DoctorCastle Connolly
  6. 2005
    Workshop Award for Accelerating Anticancer Agent Development and Validation WorkshopASCO/AACR/NCI/FDA
  7. 2001
    Workshop Award for Methods in Clinical Cancer ResearchASCO/AACR
  8. 1999
    Oliver Smith Award for Excellence in Patient CareTufts-New England Medical Center
  9. 1992
    Bachelor of Science with Great DistinctionMcGill University
  10. 1987
    Dean's Honor ListAmerican University of Beirut

Professional memberships

  1. 2016 - present
    MemberHepatobiliary Cancer Task Force, National Cancer Institute
  2. 2016 - present
    MemberComprehensive Cancer Center, Mayo Clinic Cancer Center - Arizona, Mayo Clinic Cancer Center
  3. 2016 - present
    Co-LeaderHepatobiliary Cancers, Alliance for Clinical Trials in Oncology
  4. 2016 - present
    MemberData and Safety Monitoring Board, Merck
  5. 2016 - present
    ChairData Safety and Monitoring Board, ARMO Biosciences
  6. 2015
    ChairPancreas Cancer Education Session, American Society of Clinical Oncology
  7. 2015 - present
    MemberData Safety and Monitoring Board, Sillajen
  8. 2014
    Ad Hoc ReviewerPancreatic Cancer Research Fund (UK)
  9. 2014
    Ad Hoc ReviewerThe Wellcome Trust/DBT India Alliance Grants
  10. 2014 - present
    MemberSouthwest Oncology Group
  11. 2014 - present
    Co-ChairPancreas Cancer Subcommittee, Southwest Oncology Group
  12. 2014 - present
    MemberGI Cancer Leadership Working Group, Southwest Oncology Group
  13. 2014 - present
    MemberASSIGN Trial Therapeutics Committee, National Cancer Institute
  14. 2014 - present
    MemberPancreas Cancer Working Group, Alliance for Clinical Trials in Oncology
  15. 2013 - 2016
    MemberAppointments, Promotion and Tenure Committee, The Ohio State University
  16. 2013 - 2016
    MemberTranslational Therapeutics Program, The Ohio State University Comprehensive Cancer Center
  17. 2013 - 2016
    MemberGrateful Patient Pilot Program, The Ohio State University
  18. 2013 - 2014
    MemberDigestive Diseases Executive Committee, The Ohio State University-Wexner Medical Center
  19. 2013 - 2014
    Industrial ConsultantAstra-Zeneca
  20. 2013
    Ad Hoc ReviewerCancer Research UK Centres
  21. 2013 - present
    MemberGastrointestinal Cancer-Non-Colorectal Tract, Cancer Education Committee, American Society of Clinical Oncology
  22. 2013 - present
    ChairData and Safety Monitoring Board, Exelexis
  23. 2013 - present
    Chief EditorCollabRx Inc.; Colorectal Cancer
  24. 2012 - 2016
    MemberFinance Committee, Division of Medical Oncology, The Ohio State University-James Cancer Hospital and Solove Research Institute
  25. 2012 - 2016
    MemberLeadership Committee, Division of Medical Oncology, The Ohio State University-James Cancer Hospital and Solove Research Institute
  26. 2012 - 2014
    Scientific ReviewerPancreas Cancer-2 Panel, Peer Reviewed Cancer Research Program (PRCRP), United States Department of Defense
  27. 2012 - 2013
    Ad Hoc ReviewerLate Phase Study, Clinical Trials Awards and Advisory Committee, Cancer Research UK
  28. 2012
    ReviewerProgram Project Research Applications, American University of Beirut
  29. 2012
    MemberMethotrexate Shortage Oversight Committee, The Ohio State University-Wexner Medical Center and James Cancer Hospital and Solove Research Institute
  30. 2012 - present
    MemberScientific and Administrative Review Committee, Academic and Community Cancer Research United (ACCRU)
  31. 2012 - present
    LeaderGI Disease Group, Academic and Community Cancer Research United (ACCRU)
  32. 2012 - present
    Industry ConsultantMerrimack Pharmaceutical
  33. 2011 - 2016
    ChairDisease Specific Research Group (DSRG) for Gastrointestinal Oncology, The Ohio State University Comprehensive Cancer Center
  34. 2011 - 2014
    GI LiaisonQuality of Life Subcommittee, Alliance for Clinical Trials in Oncology
  35. 2011 - 2014
    MemberPrevention Committee, Alliance for Clinical Trials in Oncology
  36. 2011 - 2013
    MemberSearch Committee, The Ohio State University
  37. 2011 - 2013
    MemberColorectal Cancer, Oncology Outcomes Database Disease Specific Executive Committee (DSEC), National Comprehensive Cancer Network (NCCN)
  38. 2011 - 2012
    MemberPelotonia Grant Review Committee, The Ohio State University Comprehensive Cancer Center
  39. 2011 - 2012
    MemberPaclitaxel Shortage Oversight Commitee, The Ohio State University-Wexner Medical Center and James Cancer Hospital and Solove Research Institute
  40. 2011
    MemberMEK Scientific Review Committee, BRAF and MEK Request for Proposals Development Teams (RFPDTs), National Comprehensive Cancer Network (NCCN)
  41. 2011
    MemberBRAF and MEK Request for Proposals Development Teams (RFPDTs), National Comprehensive Cancer Network (NCCN)
  42. 2011 - present
    Cadre MemberGI Committee, Alliance for Clinical Trials in Oncology
  43. 2011 - present
    MemberColon/Rectrum/Anal Cancer Panel, National Comprehensive Cancer Network (NCCN)
  44. 2010 - 2016
    MemberACS Grant Review Committee, The Ohio State University Comprehensive Cancer Center
  45. 2010 - 2016
    MemberMedical Student Research (MDSR), Faculty Advisory Committee, The Ohio State University College of Medicine
  46. 2010 - 2016
    MemberFellows Competency Committee, The Ohio State University-Wexner Medical Center and James Cancer Hospital and Solove Research Institute
  47. 2010 - 2015
    Industry ConsultantBristol Meyers Squibb
  48. 2010 - 2015
    MemberData Safely and Monitoring Board, Polaris Group
  49. 2010
    Ad Hoc ReviewerEminent Scholar, Kansas Bioscience Authority, Kansas State University
  50. 2010
    Scientific ReviewerColorectal Cancer Panel, Peer Reviewed Cancer Research Program (PRCRP), United States Department of Defense
  51. 2010
    Ad Hoc ReviewerBiomarkers and Imaging Discovery and Development Committee, Cancer Research UK
  52. 2010
    MemberScientific Program Committee, American Association for Cancer Research (AACR)
  53. 2010
    MemberPlanning Committee, Scientific Program Committee, Collaborative Group of the Americas on Inherited Colorectal Cancer
  54. 2010
    Co-ChairGastrointestinal (Colorectal) Cancer, American Society of Clinical Oncology
  55. 2010 - present
    Industrial ConsultantMcKesson Corporation
  56. 2009 - 2015
    Industrial ConsultantArray BioPharma Inc
  57. 2009 - 2011
    MemberFeasibility Review Committee, The Ohio State University Comprehensive Cancer Center
  58. 2009 - 2011
    Academic ConsultantLebanese-American University
  59. 2009 - 2011
    MemberScientific Program Committee, American Society of Clinical Oncology
  60. 2009 - 2011
    MemberContinuing Medical Education Subcommittee, American Society of Clinical Oncology
  61. 2009 - 2011
    Industry ConsultantMersana Therapeutics
  62. 2009
    Co-ChairHepatobiliary Cancer Research Session, American Association for Cancer Research
  63. 2009
    MemberColon Cancer Panel, Institute for Pharmacy Outcomes of the Rx, Ohio Collaborative Group
  64. 2008 - 2011
    MemberGastrointestinal Cancer-Colorectal/Liver Track, Scientific Program Committee, American Society of Clinical Oncology
  65. 2008 - 2011
    MemberHoosier Oncology Group; GI Clinical Trial Working Group
  66. 2008 - present
    Expert ReviewerThe Italian Association for Cancer Research (AIRC)
  67. 2007 - 2011
    Cadre MemberGI Committee, Cancer and Leukemia Group B
  68. 2007 - 2011
    GI LiaisonQuality of Life Subcommittee, Cancer and Leukemia Group B
  69. 2007 - present
    Industry ConsultantGenentech
  70. 2006 - 2013
    Advisory PanelistNetWellness, University of Cincinnati and The Ohio State University and Case Western Reserve University
  71. 2006
    ReviewerAD Hoc Review External Committee (RAID Program), National Cancer Institute
  72. 2005 - 2012
    Panel MemberColorectal Cancer, Patient Navigation Research Program, National Cancer Institute
  73. 2005 - 2006
    MemberFellowship Recruitment Committee, The Ohio State University-Wexner Medical Center and James Cancer Hospital and Solove Research Institute
  74. 2004 - 2016
    MemberClinical Scientific Review Executive Committee, The Ohio State University Comprehensive Cancer Center
  75. 2004 - 2011
    ChairGastrointestinal Cancers Disease Specific Committee, The Ohio State University Comprehensive Cancer Center
  76. 2004 - 2010
    MemberGastric Cancer Panel and Writing Member, National Comprehensive Cancer Network (NCCN)
  77. 2004 - 2010
    MemberEsophageal Cancer Panel and Writing Member, National Comprehensive Cancer Network (NCCN)
  78. 2003 - 2016
    ChairHematology-Oncology Formulary Subcommittee Group, The Ohio State University-James Cancer Hospital
  79. 2003 - 2016
    MemberThe Ohio State University Comprehensive Cancer Center
  80. 2003 - 2012
    MemberExperimental Therapeutics Program, The Ohio State University Comprehensive Cancer Center
  81. 2003 - 2012
    Founding MemberGastrointestinal Oncology Multi-Modality Steering Committee, The Ohio State University Hospitals
  82. 2003 - 2012
    MemberPharmacy and Therapeutics, Policy and Surveillance Executive Committee, The Ohio State University Hospitals
  83. 2003 - 2006
    MemberHepatobiliary Panel, National Comprehensive Cancer Network (NCCN)
  84. 2003 - 2005
    MemberClinical Patient Safety Committee, The Ohio State University Hospitals
  85. 2001 - present
    MemberAmerican Association for Cancer Research (AACR)
  86. 2000 - 2012
    MemberAmerican Society for Clinical Pharmacology and Therapeutics
  87. 1999 - present
    MemberAmerican Society of Clinical Oncology
  88. 1996 - present
    MemberAmerican College of Physicians-American Society of Internal Medicine
  89. 1996 - present
    MemberLebanese Order of Physicians

Publications